Conference
Molecule Life Cycle Management: POM to P to GSL
Medicine · Pharmaceuticals · Biotechnology
Key numbers
- Editions on record
- 1first in 2011
About Molecule Life Cycle Management: POM to P to GSL
The considerable decline in the number of approved POM-P switches in recent years, despite early success highlights the need to address the issue. SMi Group provides a CPD accredited masterclass which helps those who want to find out more about making the switch from POM-P and P-GSL and enables industry professionals to discuss the challenges and develop strategies for them.
Reasons for attending:
•Acquire an understanding of the current legalisation and
•Gain an insight from previous unsuccessful POM-P switches and how to avoid their pitfalls
•Examine the changing regulatory switch environment
•Discuss the lessons learned for future switching
•Assess the business model of the POM-P process
•Learn from an extremely experienced industry professional with over three decades of pharmaceutical experience.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2011 | 12 May 2011 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Molecule Life Cycle Management: POM to P to GSL?
The next dates haven't been confirmed. The last edition we have on record was 12 May 2011.